AQR Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,723
| Closed | -$250K | – | 2796 |
|
|
2024
Q2 | $250K | Sell |
28,723
-30,353
| -51% | -$264K | ﹤0.01% | 2341 |
|
|
2024
Q1 | $1.22M | Buy |
59,076
+34,808
| +143% | +$719K | ﹤0.01% | 1611 |
|
|
2023
Q4 | $561K | Buy |
24,268
+8,940
| +58% | +$207K | ﹤0.01% | 1834 |
|
|
2023
Q3 | $122K | Buy |
+15,328
| New | +$122K | ﹤0.01% | 2208 |
|
|
2022
Q3 | – | Sell |
-13,921
| Closed | -$110K | – | 2240 |
|
|
2022
Q2 | $110K | Buy |
13,921
+282
| +2% | +$2.23K | ﹤0.01% | 2080 |
|
|
2022
Q1 | $166K | Sell |
13,639
-1,211
| -8% | -$14.7K | ﹤0.01% | 2090 |
|
|
2021
Q4 | $182K | Buy |
+14,850
| New | +$182K | ﹤0.01% | 2103 |
|
|
2015
Q3 | – | Sell |
-1,679
| Closed | -$63K | – | 2192 |
|
|
2015
Q2 | $63K | Sell |
1,679
-1,351
| -45% | -$50.7K | ﹤0.01% | 2189 |
|
|
2015
Q1 | $120K | Sell |
3,030
-840
| -22% | -$33.3K | ﹤0.01% | 2067 |
|
|
2014
Q4 | $159K | Hold |
3,870
| – | – | ﹤0.01% | 2402 |
|
|
2014
Q3 | $171K | Hold |
3,870
| – | – | ﹤0.01% | 2383 |
|
|
2014
Q2 | $168K | Hold |
3,870
| – | – | ﹤0.01% | 2403 |
|
|
2014
Q1 | $159K | Buy |
+3,870
| New | +$159K | ﹤0.01% | 2466 |
|